antimicrobi
resist
continu
increas
advers
affect
mortal
morbid
major
risk
factor
remain
larg
volum
antibiot
prescrib
primari
secondari
care
rise
easili
transmiss
genet
element
encod
resist
lastlin
antimicrobi
rais
real
possibl
postantibiot
era
rapid
accur
diagnosi
would
allow
reduct
volum
antimicrobi
prescript
respiratori
tract
infect
remain
major
caus
mortal
morbid
worldwid
henc
driver
antimicrobi
prescript
howev
primari
care
infect
often
viral
selflimit
antimicrobi
prescript
necessari
exampl
estim
million
antimicrobi
prescript
issu
annual
rti
unit
state
million
unnecessari
thu
press
need
novel
pointofcar
poc
invitro
diagnost
reduc
prescript
antimicrobi
respiratori
tract
infect
rti
primari
care
analysi
volatil
organ
compound
voc
exhal
breath
potenti
strategi
noninvas
poc
diagnosi
exclus
bacteri
infect
date
analysi
voc
human
excret
suggest
potenti
role
diagnosi
cancer
inflammatori
bowel
diseas
gastric
respiratori
infect
chronic
obstruct
pulmonari
diseas
cystic
fibrosi
diagnosi
ventilatorassoci
pneumonia
vap
amongst
entiti
studi
attempt
identifi
voc
signatur
associ
bacteri
infect
unselect
popul
present
rti
number
avail
technolog
use
detect
voc
clinic
sampl
andor
directli
patient
gold
standard
voc
detect
ga
chromatographymass
spectrometri
gcm
allow
identif
individu
voc
howev
instrument
larg
expens
cumbersom
usual
laboratori
base
requir
special
staff
oper
interpret
data
thu
analysi
sampl
collect
patient
often
separ
furthermor
detect
low
concentr
ga
phase
biomark
requir
use
form
preconcentr
system
typic
achiev
use
absorb
tube
use
materi
follow
desorpt
gcm
analysi
attempt
solv
limit
research
appli
electron
nose
instrument
similar
applic
reader
refer
recent
review
comprehens
descript
electron
nose
devic
potenti
use
respiratori
medicin
brief
howev
instrument
attempt
replic
biolog
olfactori
system
reli
array
commerci
avail
ga
sensor
overlap
sensit
abl
analyz
sampl
whole
instrument
made
smaller
cheaper
gcm
use
air
carrier
ga
requir
minim
train
use
though
shown
promis
mani
instrument
either
requir
sensit
repeat
requir
clinic
set
recent
develop
solv
issu
gascapillari
column
ion
mobil
spectromet
gcim
instrument
gc
compon
undertak
separ
complex
chemic
mixtur
im
detect
separ
chemic
ultrahigh
sensit
part
per
trillion
hypothes
gcim
instrument
could
use
collect
exhal
breath
sampl
bedsid
could
distinguish
bacteri
viral
rti
therefor
perform
prospect
cross
section
proofofconcept
studi
hospitalis
patient
diagnosi
rti
order
assess
feasibl
techniqu
ga
analysi
instrument
use
commerci
avail
breathspec
gcim
imspex
uk
attach
nitrogen
gener
lehman
franc
mount
hospit
trolley
could
brought
patient
bedsid
patient
deliv
breath
sampl
directli
machin
exhal
dispos
mouthpiec
patient
ask
inhal
exhal
singl
deep
breath
last
three
second
exhal
breath
collect
analysi
ensur
analysi
endtid
breath
exhal
breath
requir
greater
second
typic
second
patient
deliv
breath
less
three
second
time
devic
ask
repeat
result
voc
analys
store
devic
intern
memori
later
download
review
potenti
strong
flavour
food
drink
produc
erron
result
patient
ask
eat
noth
drink
water
minut
prior
provid
sampl
remain
complet
nil
mouth
minut
prior
provid
sampl
although
longer
fast
period
use
research
practic
within
secondari
care
set
period
time
best
achiev
ambient
air
sampl
collect
breath
sampl
comparison
immedi
collect
patient
breath
sampl
room
patient
deliv
sampl
allow
background
air
contamin
subtract
patient
sampl
total
analysi
time
sampl
minut
fig
show
typic
output
breathspec
use
patient
sampl
patient
classifi
confirm
bacteri
viral
probabl
bacteri
viral
basi
investig
shown
tabl
case
definit
chosen
high
posit
predict
valu
discrimin
bacteri
viral
rti
rather
correctli
classifi
patient
recognis
unlik
possibl
avail
test
patient
meet
confirm
probabl
bacteri
viral
classif
assign
classif
data
analysi
undertaken
use
r
r
foundat
statist
comput
vienna
austria
summari
statist
calcul
compar
two
patient
group
mean
standard
deviat
normal
distribut
continu
variabl
median
interquartil
rang
nonnorm
distribut
continu
variabl
proport
categor
variabl
two
sampl
ttest
use
compar
normal
distribut
variabl
group
wilcoxon
rank
sum
test
compar
nonnorm
distribut
variabl
fisher
exact
test
proport
throughout
p
valu
consid
statist
signific
exploratori
natur
studi
formal
power
calcul
perform
estim
previou
voc
studi
two
group
patient
would
probabl
identifi
signific
differ
voc
spectrum
two
group
purpos
compar
gcim
data
patient
split
two
bacteri
rti
consist
confirm
probabl
bacteri
rti
data
analysi
voc
sampl
consist
unsupervis
dimension
reduct
step
follow
classif
step
crossvalid
use
assess
diagnost
perform
gcim
data
high
dimension
conveni
reduc
via
dimension
reduct
ie
compress
step
appropri
inform
contain
within
data
expect
much
lowerdimension
exampl
number
inform
compound
much
lower
number
measur
valu
per
sampl
done
use
spars
princip
compon
analysi
known
prior
work
give
good
perform
gcim
type
data
use
elbow
plot
determin
data
spars
princip
compon
pc
learn
input
data
pc
use
input
crossvalid
use
spars
logist
regress
predict
outcom
standard
pipelin
paramet
set
use
algorithm
guard
overfit
ie
paramet
tune
perform
use
current
data
set
sensit
specif
receiveroperatorcurv
confid
interv
calcul
studi
receiv
ethic
approv
nh
south
westexet
research
ethic
committe
refer
particip
provid
written
inform
consent
patient
without
capac
provid
inform
consent
recruit
patient
screen
amu
studi
period
patient
recruit
addit
patient
recruit
via
microbiolog
laboratori
confirm
viral
rti
expand
second
phase
recruit
patient
approach
declin
enrol
studi
fig
show
flow
patient
studi
tabl
show
characterist
studi
particip
sever
statist
signific
differ
group
unequ
sex
distribut
significantli
higher
respiratori
rate
lower
oxygen
satur
higher
total
white
count
neutrophil
count
lower
lymphocyt
count
bacteri
group
benzylpenicillin
therapi
bacteri
group
total
patient
least
one
microbiolog
sampl
sent
detail
sampl
sent
pathogen
identifi
shown
tabl
final
diagnost
model
produc
area
receiv
oper
characterist
curv
auc
roc
ci
discrimin
bacteri
sampl
summari
test
characterist
sensit
ci
specif
ci
fig
studi
demonstr
first
time
feasibl
voc
analysi
use
portabl
gcim
instrument
exhal
breath
sampl
patient
bedsid
identifi
bacteri
rti
unselect
medic
inpati
admit
diagnosi
rti
accuraci
cohort
moder
auc
ci
test
procedur
well
toler
patient
agre
provid
breath
sampl
abl
despit
hospit
around
patient
receiv
supplement
oxygen
vast
major
elig
patient
approach
agre
particip
sever
limit
studi
mean
result
interpret
caution
either
due
small
sampl
size
exploratori
natur
studi
firstli
diagnost
algorithm
valid
extern
cohort
secondli
rate
microbiolog
test
perform
cohort
low
patient
sputum
cultur
sent
throat
swab
sent
viral
multiplex
pcr
result
patient
confirm
bacteri
viral
infect
major
patient
classifi
probabl
bacteri
viral
rti
basi
proxi
radiograph
biochem
test
chest
radiographi
crp
rather
microbiolog
test
although
evid
crp
greater
associ
bacteri
rti
crp
less
viral
rti
crp
imperfect
test
purpos
crp
marker
system
inflamm
also
possibl
defin
group
way
done
split
diseas
sever
rather
aetiolog
evid
case
bacteri
rti
group
significantli
lower
oxygen
satur
higher
respiratori
rate
marker
sever
diseas
situat
differ
voc
signatur
could
relat
sever
specif
host
respons
diseas
rather
aetiolog
agent
low
rate
microbiolog
test
cohort
also
rais
possibl
select
bia
patient
chosen
sputum
cultur
viral
multiplex
pcr
attend
clinician
may
differ
way
undergo
test
made
problemat
fact
low
number
posit
viral
pcr
result
forc
us
recruit
patient
identifi
laboratori
posit
result
fact
major
patient
confirm
viral
rti
group
recruit
way
anoth
potenti
sourc
select
bia
could
introduc
differ
bacteri
rti
rti
group
problem
low
rate
identif
caus
organ
one
common
lrti
aetiolog
studi
clinic
care
thirdli
exploratori
natur
studi
small
number
preclud
analysi
take
account
diseas
known
affect
voc
profil
diabet
mellitu
copd
etc
fourthli
decis
made
use
washin
particip
breath
clean
scrub
air
prior
exhal
devic
principl
could
result
ambient
air
voc
erron
attribut
patient
decis
made
may
uncomfort
patient
popul
interest
patient
hospit
respiratori
tract
infect
mitig
misattribut
ambient
air
sampl
sampl
room
air
collect
patient
event
background
air
variat
small
addit
unit
use
gc
presepar
like
interf
molecul
detect
separ
biomark
wash
critic
situat
final
sensit
specif
techniqu
best
modest
may
heterogen
studi
popul
addit
factor
contribut
notwithstand
limit
pilot
studi
demonstr
feasibl
besid
point
voc
hospit
unselect
rti
popul
clinic
studi
need
valid
techniqu
much
larger
patient
set
use
comprehens
diagnost
microbiolog
robust
case
definit
agre
expert
panel
enabl
distinct
made
patient
differ
underli
condit
emphysema
diabet
